Our Founder & President,
@khrystalkdavis
took a strong position against PBMs in her op-ed calling for reform. Since PBMs emerged, patients face increasing barriers to access and pay more out of pocket for the medications they need. bit.ly/3Gsb3LK
Learn how the #PBM business model is misaligned between the interests of the #PBMs and the stakeholders they claim to serve. drugstorenews.com/reforming-…
There is an alarming shortage of some injectable drugs for #cancer and other life-threatening diseases, the result of misdirected government policies. It’s time for #340B reform. Put patients first. is.gd/Bwte7J
“Earlier this month, Grassley told Reuters the #PBM system was ‘an opaque operation. Transparency brings accountability, and there’s no accountability.’” is.gd/j0vFVu
#PBM compensation and the list price of a medicine create an incentive for #PBMs to prefer higher list prices. Delinking this compensation arrangement could save an estimated $39.9 billion over a 10-year period. is.gd/KE21tN
A big thank you to our own Senator @JohnCornyn for joining with the 24 cosponsors of the #MCED Screening Coverage Act to create a pathway for early cancer detection for Texans on Medicare.
Patients should benefit from negotiated drug discounts. Right now, only #PBMs benefit – and this overcharging must stop. We urge @WaysMeansCmte@WaysandMeansGOP to fix this. Help patients save at the pharmacy counter with this #PBMreform.
Lean how the #340B program is potentially and unnecessarily encouraging the purchase of higher-priced prescription meds, which may inflate costs for patients. is.gd/qx1QhG
Drug discounts that benefit only #PBMs should be shared with patients. We hope this important #PBMreform is top of mind for @SenFinance members as they discuss #PBM accountability and PBM overcharging of patients. Thank you, Sen. @JohnCornyn for your attention to this issue.
Drug discounts that benefit only #PBMs should be shared with patients. We hope this important #PBMreform is top of mind for @SenFinance members as they discuss #PBM accountability and PBM overcharging of patients. Thank you, Sen. @JohnCronyn for your attention to this issue.
Learn about the misaligned incentives regarding the role of #PBMs, the massive corporate middlemen in the drug supply chain. “Incentives” = profit-making opportunities for the largest PBMs. natlawreview.com/article/mid…
500+ organizations nationwide signed onto a letter urging Congress to pass the #MCEDAct this year, which would give seniors access to life-saving multi-cancer early detection (#MCED) tests. @SenTedCruz@JohnCornynbit.ly/3qZBDc5